Double-blind, double-dummy, randomized, crossover, multicentre phase IV clinical study comparing the effect of Ursofalk® 500 mg tablets od versus Ursofalk® 250 mg capsules od on liver enzyme parameters in the treatment of primary biliary cirrhosis - Ursofalk® tablets versus Ursofalk®capsules in the treatment of PBC Double-blind, double-dummy, randomized, crossover, multicentre phase IV clinical study comparing the ...
Double-blind, double-dummy, randomized, crossover, multicentre phase IV clinical study comparing the effect of Ursofalk® 500 mg tablets od versus Ursofalk® 250 mg capsules od on liver enzyme parameters in the treatment of primary biliary cirrhosis - Ursofalk® tablets versus Ursofalk®capsules in the treatment of PBC Double-blind, double-dummy, randomized, crossover, multicentre phase IV clinical study comparing the ...
Double-blind, double-dummy, randomized, crossover, multicentre phase IV clinical study comparing the effect of Ursofalk® 500 mg tablets od versus Ursofalk® 250 mg capsules od on liver enzyme parameters in the treatment of primary biliary cirrhosis - Ursofalk® tablets versus Ursofalk®capsules in the treatment of PBC Double-blind, double-dummy, randomized, crossover, multicentre phase IV clinical study comparing the ...
Double-blind, double-dummy, randomized, crossover, multicentre phase IV clinical study comparing the effect of Ursofalk® 500 mg tablets od versus Ursofalk® 250 mg capsules od on liver enzyme parameters in the treatment of primary biliary cirrhosis - Ursofalk® tablets versus Ursofalk®capsules in the treatment of PBC Double-blind, double-dummy, randomized, crossover, multicentre phase IV clinical study comparing the ...